Bioptik Technology Incorporation reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was TWD 199.16 million compared to TWD 103.36 million a year ago. Net income was TWD 11.17 million compared to net loss of TWD 23.52 million a year ago. Basic earnings per share from continuing operations was TWD 0.23 compared to basic loss per share from continuing operations of TWD 0.49 a year ago. Diluted earnings per share from continuing operations was TWD 0.23 compared to diluted loss per share from continuing operations of TWD 0.49 a year ago. For the nine months, sales was TWD 535.79 million compared to TWD 343.71 million a year ago. Net income was TWD 17.38 million compared to net loss of TWD 43.68 million a year ago. Basic earnings per share from continuing operations was TWD 0.36 compared to basic loss per share from continuing operations of TWD 0.9 a year ago. Diluted earnings per share from continuing operations was TWD 0.36 compared to diluted loss per share from continuing operations of TWD 0.9 a year ago.